Warner Biddle
CEO & DirectorMr. Warner Biddle serves as CEO & Director of Kyverna Therapeutics, Inc. since September 16, 2024. He serves as Director of Alliance for Regenerative Medicine. He was Ad Interim Head of Kite at Kite Pharma, Inc. from 2023 until February 2025. He was Global Head of Commercial of Kite Pharma, Inc. from 2020 until February 2025. Before joining Kite Pharma, Inc., he served as Vice President for the Breast/Gynecologic and Skin Cancer Franchises at Genentech. There he successfully led the cross-functional strategy and launches for several commercial and pipeline products while driving significant portfolio growth. Prior to his oncology roles, he served as Vice President, Sales and Marketing for Ophthalmology at Genentech and also held various global leadership roles in Europe and Canada across multiple therapeutic disease areas at Novartis and GlaxoSmithKline. He received a bachelor’s degree in commerce with Honors from the University of Saskatchewan.
Positions
- Company NameKyverna Therapeutics, Inc.Stock CodeKYTXPositionCEO & Director
